Position in FHTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$193,160
+$4,327 QoQ
Shares Held
39,582
+0.2% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 102 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in FHTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. FHTX ranks #248 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in FHTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $193,160 | 39,582 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $188,833 | 39,505 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $216,631 | 40,117 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $213,805 | 43,723 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $207,575 | 44,165 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $132,294 | 36,245 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $171,732 | 36,384 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $310,348 | 33,335 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $206,482 | 35,910 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $179,418 | 26,739 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $167,448 | 25,961 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $132,130 | 26,426 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $179,006 | 25,427 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $156,946 | 25,314 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $164,291 | 25,751 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $212,595 | 24,778 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $313,847 | 23,077 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $345,355 | 22,676 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $444,890 | 19,453 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $257,342 | 18,474 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $167,081 | 15,659 | Shares | Sole | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||